• Post-prandial hyperinsulinaemic hypoglycaemia (PPHH) or late dumping syndrome is a recognized complication of various gastric surgeries.
Introduction
Post-prandial hyperinsulinaemic hypoglycaemia (PPHH) or "late dumping syndrome" is the effect of altered gastric reservoir function, abnormal post-operative gastric motor function and/or abnormal pyloric emptying mechanism. PPHH is a recognized complication observed after a variety of gastric surgical procedures such as vagotomy, pyloroplasty, gastrojejunostomy, and laparoscopic Nissen fundoplication [1, 2] .
In childhood, the surgical treatment of gastro-oesophageal reflux by gastric fundoplication is the main cause of PPHH [2] [3] [4] [5] . PPHH after oesophageal atresia repair without anti-reflux surgery is rare. In the literature, there are 3 published cases [6, 7] of children with oesophageal atresia who presented with PPHH without any known precipitating factors, such as gastro-oesophageal reflux surgery or associated microgastria. The possible mechanism is a disorder of gastric motor activity in patients following operative repair of oesophageal atresia [8, 9] .
In this article, we report the initial symptoms, investigations, and the therapeutic challenges in 2 children diagnosed with PPHH after surgical repair of oesophageal atresia without anti-reflux surgery.
Case Report
Case 1 An 11-month-old boy presented with an episode of seizure due to hypoglycaemia and consequently a head injury, with normal CT scan of the head. He was the first child of healthy, unrelated parents, with no family history of hypoglycaemia. Scans at 12 and 20 weeks were normal, but polyhydramnios was diagnosed at 32 weeks' gestation. He was delivered by normal vaginal delivery at 38 weeks' gestation weighing 2.5 kg (-1.9 SDS). He was found to have a long-gap oesophageal atresia (without fistula) and on day 3 of life, a gastrostomy was performed to facilitate feeding. At his first assessment, the gap was estimated to be 4.5 vertebral bodies and a second gap assessment at the age of 40 days confirmed a gap of 3 vertebral bodies. He had a delayed primary anastomosis for long-gap oesophageal atresia 3 months after gap assessment and gastrostomy formation. Furthermore, the baby was diagnosed with patent ductus arteriosus, which was medically treated. During the first year of life, he required 6 oesophageal dilatations for strictures and was entirely gastrostomy fed.
Further biochemical investigations (Table 1 ) at the age of 11 months, when he presented with hypoglycaemic seizures, confirmed PPHH as he developed hypoglycaemia (capillary glucose 2.6 mmol/L and laboratory glucose of 2.3 mmol/L), preceded by detectable insulin of 3.0 mU/L at 90 min of a mixed meal test performed with his milk feeds (Peptijunior ® ) at a volume of 20% of his estimated average requirement given over an hour via gastrostomy. Repeated mixed meal showed PPHH as he developed hypoglycaemia (laboratory glucose 2.9 mmol/L) with detectable insulin of 4.3 mU/L at 120 min.
However, the child had a normal fast tolerance and no hypoglycaemia on protein load test. His metabolic screen (including acyl carnitine profile, plasma amino acids, and urine organic acids) and array CGH chromosomes were normal. He had a normal growth hormone peak of 26.9 μg/L at a glucagon stimulation test.
Initially, he was treated with acarbose, which was gradually increased up to a maximum dose of 75 mg in 3 divided doses, and a feeding regimen of 3 hourly bolus gastrostomy feeds during the daytime and continuous feeds overnight. He showed no response and therefore acarbose was stopped and he was commenced on diazoxide, but, unfortunately, he was unresponsive to this. Finally, he was managed with 18 h of continuous gastrostomy feeds and 2 breaks of 3 h during the day.
He is currently asymptomatic after 16 months of follow-up, with normal growth and developmental progress. He is on 12-h continuous feeds overnight, with 2 small bolus feeds (100 mL) during the day given over an hour, and solid food on demand orally. On this feeding regimen, he achieves normoglycaemia during a 24-h glucose profile (capillary glucose ranges from 3.5 to 5.0 mmol/L) and he is able to fast for 10 h. His overnight feeds will now be slowly reduced if he has an adequate intake of calories orally.
Case 2
A 6-month-old female was antenatally diagnosed with WolfHirschhorn syndrome. She was born at 38 +3 weeks of gestation, with a birth weight of 2,040 g (-2.72 SDS) by an elective C-section in poor condition, requiring resuscitation. At birth, she was found to have oesophageal atresia and trachea-oesophageal fistula that was surgically repaired on the second day of life. She had a pri- mary anastomosis for long-gap oesophageal atresia under some tension and did not require an oesophageal replacement. A prolonged stay in the neonatal unit followed this in order to establish oral feeds. Meanwhile, she was diagnosed with a duplicated gall bladder, short long bones, double superior vena cava with atrial septal defect and hypoplastic kidneys; all of these features were consistent with Wolf-Hirschhorn syndrome, which was confirmed by microarray whereby a microdeletion of the short (p) arm of chromosome 4 was found (4p16.3p 16.2 [51, 120-5, 150, 630] × 1).
Over the following months, she developed strictures at the anastomosis site, requiring oesophageal dilatation. During the post-operative period, she exhibited increased sleepiness and, when tested at the age of 5 months, she was found to be hypoglycaemic.
Further biochemical investigations (Table 1) confirmed PPHH as she developed hypoglycaemia (laboratory glucose of 1.9 mmol/L), along with detectable higher concentrations of insulin (17.6 mU/L) and C-peptide (2,439 pmol/L), with low non-esterified fatty acids of 0.25 mmol/L and β-hydroxybutyrate of 0.11 mmol/L at 60 min following bolus feed via nasogastric tube. Repeat hyposcreen results confirmed PPHH after developing hypoglycaemia 1 h following bolus milk feed (100 mL over 1 h; laboratory glucose 1.8 mmol/L, insulin 32.6 mU/L, C-peptide 2,439 pmol/L, non-esterified fatty acids 0.37 mmol/L, β-hydroxybutyrate 0.17 mmol/L).
She was able to fast for 8 h without developing hypoglycaemia and this ruled out fasting hyperinsulinaemic hypoglycaemia. Her metabolic screen (including acyl carnitine profile, plasma amino acids, and urine organic acids) was normal. She had a gastric emptying study that was reported as normal. In view of her age and weight, the glucagon stimulation test was not performed as it was deemed to be unsafe, but she had an adequate growth hormone level of 8.7 μg/L during an episode of hypoglycaemia.
Initially, she was commenced on diazoxide (maximum dose of 7 mg/kg/day in 3 divided doses), and showed a good response to it. However, this triggered pulmonary hypertension and eventually diazoxide had to be stopped. Finally, a gastrostomy was performed and PPHH was managed with 20 h continuous gastrostomy feeds and 2 hourly breaks twice per day, while she was allowed small amounts of puree orally in order to preserve her orality. Her repeat echocardiogram after 2 weeks showed complete resolution of pulmonary hypertension.
On her most recent visit at the age of 9 months, she is thriving with stable blood glucose concentrations on 19 h of continuous gastrostomy feeds and we are considering increasing her break time from 2.5 h to 3 h. She has been thoroughly investigated for severe and persistent gastro-oesophageal reflux symptoms by an impedance study that showed non-acid gastro-oesophageal reflux and an oesophagogastroduodenoscopy that confirmed gastritis with eosinophilic infiltration. Finally, her symptoms were controlled with prokinetic therapy and currently she requires fewer oesophageal dilatations.
Discussion
PPHH or late dumping syndrome manifests as nonspecific symptoms 1-3 h after a meal, with signs and symptoms of hypoglycaemia. The pathogenesis is likely related to the early development of hyperinsulinaemic (reactive) hypoglycaemia [1] . Calabria et al. [2] demonstrated that the exaggerated insulin response to a meal, seen in children with post-prandial hypoglycaemia after gastric surgery, is at least in part due to the effects of GLP-1 on the pancreatic β-cell, as the blockade of the GLP-1 receptor with exendin (9-39) blunted the insulin response even in the presence of hyperglycaemia.
In childhood, the surgical treatment of gastroesophageal reflux remains the commonest cause of PPHH [3, 4, 5, 10] . Other causes of PPHH in children caused by abnormal gastrointestinal anatomy are very rare and include congenital microgastria, partial or total gastrectomy, accidental intraduodenal or jejunal administration of bolus feeding, or inadequate meals with high osmolarity, as well as rare cases of generalized autonomic dysfunction [3, 11] . It is also rarely described as idiopathic PPHH in children without a known underlying cause [12] .
In children with oesophageal atresia, most reported cases of PPHH have been related to the surgical treatment of associated gastro-oesophageal reflux [13, 14] . There are very few paediatric case reports that report PPHH following oesophageal repair without any known precipitating factors such as gastro-oesophageal reflux surgery or associated microgastria [6, 7] . The possible mechanism is a disorder of gastric motor activity in patients following operative repair of oesophageal atresia [8, 9] . Montgomery et al. [8] showed a delayed gastric emptying in patients who have repaired oesophageal atresia. Meanwhile, the role of GLP-1 that was proved to play a key role in PPHH in children after gastric surgery [2] needs to be investigated in children with PPHH following oesophageal atresia repair. Children with PPHH can present either acutely, with life-threatening symptoms such as hypoglycaemic seizures, or they could be asymptomatic. Thus, it is important to screen children at risk in the post-operative period. Early detection and treatment can possibly prevent brain damage from severe hypoglycaemia.
Management of PPHH in childhood continues to be challenging as a variety of therapies have been used including uncooked cornstarch [15] , pectin [5] , octreotide [16] , acarbose [3] , diazoxide [17] , and change of feeding regimens (pertaining composition, volume and rate) [18] . All of these therapeutic options have limited responses as observed in our first case, or have side effects as observed in our second case that developed diazoxideinduced pulmonary hypertension [19] . Therefore, children with PHHH may require continuous feeds to achieve glycaemic control, until this condition becomes milder and improves over time, as shown by our first case.
PPHH can occur after surgical repair of oesophageal atresia without anti-reflux surgery and it may present post-prandially with classical hypoglycaemic symptoms or may be asymptomatic. Thus, it is important to monitor closely for symptoms of hypoglycaemia in children treated surgically for oesophageal atresia in the post-operative period, in order to rapidly identify those affected with PPHH and consequently commence treatment and thereby prevent potential brain injury due to severe hypoglycaemia.
